The BCA market is estimated to be worth around $3bn and growing
at a rate of 7% p.a.
It comprises around 1000 AIs distributed between 4 sectors:
microbials, plant extracts, semiochemicals and macrobials.
Of the 4 sectors microbials is by far the largest accounting
for around 60% of the estimated $3bn market, followed by
microbials, plant extracts and semiocemical.
Multiple drivers: ESG; pull from the food chain; agricultural
policy; fast track regulatory systems for BCAs; increasing
pressures on conventional crop protection products; insect, disease
and weed resistance to conventional CP products; innovation and
technological advances.
Europe and N America each account for around one 30% of the
market, with BCAs accounting for around 8-9% of each market. Asia
and Latin America account for 20% and 16% respectively.
Europe has achieved this share despite having a less favourable
regulatory environment than most other regions. This may be about
to change with recently introduced new regulations for
microorganisms.
Over 500 companies are involved in the market. They range from
large diversified companies, agricultural input companies,
agribusinesses and specialist biologicals companies, whether
start-ups or established.
A large amount of venture capital is flowing into the
sector.
The market is highly competitive, with relatively low barriers
to entry compared to those for conventional CP. For the leading
products there are multiple suppliers and brands.
This report represents a quantum leap in coverage of the BCA
sector, containing reliable, objective, validated market data and
insights based on proprietary databases and inputs from industry
leaders, cross-referenced with the wider ag input environment.
Download the Sample Report
Complete your details here to access the full sample report
